Pure Global
NCT05887947

Impact of E-cigarette Nicotine Concentration on Compensation

Impact of E-cigarette Nicotine Concentration on Compensation, Cigarette Smoking, and Biomarkers of Exposure and Harm in Diverse Smokers
University of Kansas Medical Center·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking Cessation
Drug/Device/Intervention
Electronic Cigarette Nicotine Concentration Order 1.8% 5% 1.8%
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Kansas Medical Center
Location
Kansas City, United States of America
Timeline & enrollment
Phase
N/A
Start date
Feb 20, 2023
End date
Feb 20, 2025
Enrollment
48 participants
Primary outcome

Total inhaled volume

Summary

The study will be the first to assess the impact of nicotine concentration on compensatory
 puffing (total inhaled volume), nicotine delivery, and switch patterns (percent exclusive EC,
 dual cig-EC, and cig only users) with an explicit focus on AA and White smokers.

ICD-10 classifications
Mental and behavioural disorders due to use of tobacco withdrawal stateTobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05887947
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05887947 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Kansas Medical Center and is currently Recruiting. The study focuses on Smoking Cessation. Target enrollment is 48 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.